Business
Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, announces the acceptance for publication of a research article entitled "Liposomal-Cannabidiol Injection: Preliminary Insights into Pharmacokinetics and Safety Characteristics in Göttingen Minipigs and Rabbits" in the esteemed journal Precision Nanomedicine.
About this update from Summit Hotel Properties, Inc.
[{"type":"text","content":"HERZLIYA, Israel and CALGARY, AB, July 3, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, announces the acceptance for publication of a research article entitled "Liposomal-Cannabidiol Injection: Preliminary Insights into Pharmacokinetics and Safety Characteristics in Göttingen Minipigs and Rabbits" in the esteemed journal Precision Nanomedicine.","length":501,"tagName":"p"},{"type":"image","alt":"Innocan Pharma Logo (PRNewsfoto/Innocan Pharma Corporation)","displaySize":"","headline":null,"caption":"Innocan Pharma Logo (PRNewsfoto/Innocan Pharma Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":283,"url":"https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MQ_objxOFBZ.dAp8fl2HIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ5OTtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166","width":400,"height":283}},"href":"https://mma.prnewswire.com/media/2570689/Innocan_Pharma_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The study demonstrates promising results of prolonged release and a favorable safety profile of CBD following a single subcutaneous administration of LPT-CBD in minipigs.","length":170,"tagName":"p"},{"type":"text","content":"Corporate Updates","length":17,"tagName":"p"},{"type":"text","content":"Resignation of Director and Executive Chairman","length":46,"tagName":"p"},{"type":"text","content":"Ron Mayron has resigned as Executive Chairman and a Director of the Company effective July 1, 2025. Mr. Mayron will remain with the Company for three additional months as a Special Consultant for the Company. In his place, Iris Bincovich, a current Director of the Company, will be temporarily holding the position of Chair of the Company.","length":339,"tagName":"p"},{"type":"text","content":"Iris Bincovich, Chief Executive Officer and Chair of the Company stated "we are grateful to Ron, one of the Company's founders, for his meaningful contributions over the past several years. His dedication and leadership have been greatly appreciated. We wish Ron the best of luck in his future endeavors.""...